Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID

Javier García-Abellán, Sergio Padilla, Marta Fernández-González, José A. García, Vanesa Agulló, María Andreo, Sandra Ruiz, Antonio Galiana, Félix Gutiérrez, Mar Masiá
doi: https://doi.org/10.1101/2021.03.08.21253124
Javier García-Abellán
1Internal Medicine and Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergio Padilla
1Internal Medicine and Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain
2Clinical Medicine Department, Universidad Miguel Hernández de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Fernández-González
1Internal Medicine and Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José A. García
3Statistics, Operational Research Center, Universidad Miguel Hernández, Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanesa Agulló
1Internal Medicine and Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Andreo
1Internal Medicine and Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Ruiz
4Section of Respiratory Medicine, Hospital General Universitario de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Galiana
5Microbiology Service, Hospital General Universitario de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Félix Gutiérrez
1Internal Medicine and Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain
2Clinical Medicine Department, Universidad Miguel Hernández de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gutierrez_fel@gva.es
Mar Masiá
1Internal Medicine and Infectious Diseases Unit, Hospital General Universitario de Elche, Alicante, Spain
2Clinical Medicine Department, Universidad Miguel Hernández de Elche, Alicante, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marmasiac@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective Long-term data following SARS-CoV-2 infection are limited. We aimed to characterize the medium and long-term clinical, virological, and immunological outcomes after hospitalization for COVID-19, and to identify predictors of long-COVID.

Methods Prospective, longitudinal study conducted in COVID-19 patients confirmed by RT-PCR. Serial blood and nasopharyngeal samples (NPS) were obtained for measuring SARS-CoV-2 RNA and S-IgG/N-IgG antibodies during hospital stay, and at 1, 2 and 6 months post-discharge. Genome sequencing was performed where appropriate. Patients filled out a COVID19-symptom-questionnaire (CSQ) at 2-month and 6-month visits, and those with highest scores were characterized.

Results Of 146 patients (60% male, median age 64 years) followed-up, 20.6% required hospital readmission and 5.5% died. At 2-months and 6-months, 9.6% and 7.8% patients, respectively, reported moderate/severe persistent symptoms. SARS-CoV-2 RT-PCR was positive in NPS in 11.8% (median Ct=38) and 3% (median Ct=36) patients at 2-months and 6-months, respectively, but no reinfections were demonstrated.

Antibody titers gradually waned, with seroreversion occurring at 6 months in 27 (27.6%) patients for N-IgG and in 6 (6%) for S-IgG. Adjusted 2-month predictors of the highest CSQ scores (OR [95%CI]) were lower peak S-IgG (0.80 [0.66-0.94]) and higher WHO-severity-score (2.57 [1.20-5.86]); 6-month predictors were lower peak S-IgG (0.89 [0.79-0.99]) and female sex (2.41 [1.20-4.82]); no association was found with prolonged viral shedding.

Conclusions Late clinical events and persistent symptoms in the medium and long term occurred in a significant proportion of patients hospitalized for COVID-19. Gender, severity of illness and weaker antibody responses, but not viral shedding, were associated with long-COVID.

Summary This study characterizes the long-term clinical, virological, and immunological outcomes following COVID-19 hospitalization. We found a significant proportion of late clinical events and persistent symptoms. Gender, severity of illness and weaker antibody responses, but not viral shedding, predicted long-COVID.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

FG, MM, SP and MFG were supported by RD16/0025/0038 project as a part of the Plan Nacional Research + Development + Innovation (R+D+I) and cofinanced by Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fondo Europeo de Desarrollo Regional; Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias [grant number PI16/01740; PI18/01861; CM19/00160, CM20/00066, COV20/00005]). AG was supported by COV20/00156.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Hospital General Universitario de Elche Ethics Committee (PI 46/2020).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is not publicly available due to IRB restrictions.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID
Javier García-Abellán, Sergio Padilla, Marta Fernández-González, José A. García, Vanesa Agulló, María Andreo, Sandra Ruiz, Antonio Galiana, Félix Gutiérrez, Mar Masiá
medRxiv 2021.03.08.21253124; doi: https://doi.org/10.1101/2021.03.08.21253124
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID
Javier García-Abellán, Sergio Padilla, Marta Fernández-González, José A. García, Vanesa Agulló, María Andreo, Sandra Ruiz, Antonio Galiana, Félix Gutiérrez, Mar Masiá
medRxiv 2021.03.08.21253124; doi: https://doi.org/10.1101/2021.03.08.21253124

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8794)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (493)
  • Hematology (207)
  • HIV/AIDS (396)
  • Infectious Diseases (except HIV/AIDS) (10575)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1762)
  • Nursing (104)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (966)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3992)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)